ForDoz Pharma specializes in the development and commercialization of complex injectable products. They have an internal pipeline of four leading products including liposomes, microspheres, and nanocrystals in different stages of development and are ready for licensing deals. They also offer CDMO services. ForDoz’s 27-acre campus currently includes two R&D labs, a cGMP QC/analytical laboratory, and a 13,000-ft2 state-of-the-art cGMP manufacturing facility with a dedicated cytotoxic product manufacturing suite.